Sign InTTOO Stock Analysis: Weak Fundamentals and Uncertain Predictions Limit Upside Potential
Summary
T2 Biosystems, Inc. (TTOO) is a healthcare diagnostics company with weak financial fundamentals, and while it may see a slight incline in the next trading day, its long-term potential is limited due to negative EPS, negative PE ratio, and planned share reselling, making it a Hold.
Fundamental Analysis
T2 Biosystems, Inc. (TTOO) is a healthcare diagnostics company listed on the NASDAQ. As of the last trade on September 1, 2023, the company's market cap stood at $116.75 million, with a significant number of shares outstanding (333.58 million shares).
Primarily, TTOO's financial fundamentals appear somewhat weak. The earnings per share (EPS) is at a negative $2.68, suggesting that the company is currently unprofitable. Furthermore, TTOO's negative price to earnings ratio (PE) of -0.13 also typically indicates low earning potential or high financial risk.
Technical Analysis
Analyzing TTOO from a technical perspective, it closed at $0.35, showing an 11.82% increase from the previous close. The day's trading range remained between $0.3 and $0.3642, significantly lower than the 52-week high of $6.5 and slightly higher than the 52-week low of $0.054.
The relative strength index (RSI14) stands at 48, suggesting the share is neither overbought nor oversold. However, the MACD, a trend-following momentum indicator, stands at 0.118797 for the last three months, signaling the potential start of a bullish trend.
Both the 50-day ($0.22554) and 200-day ($0.71713) moving averages are important to consider. The stock's current price is above its 50-day average, indicating a potential short-term bullish trend, but it is significantly below the 200-day average, suggesting a long-term bearish trend.
The current support level stands at $0.3425, and the resistance level is at $0.3519. Moreover, the average true range (ATR24.818039902018) suggests high intraday volatility.
Stock Performance Predictions
Taking into consideration the technical indicators and recent price movements, TTOO stock might witness a slight incline on the next trading day, September 05, 2023, owing to its current momentum. However, predicting the price for the upcoming week is uncertain due to conflicting short-term and long-term trends.
Company News and Market Environment
Recent news references T2 Biosystems as a potential penny stock worth considering, implying possible high-risk and high-reward opportunities. A considerable number of large firms, including hedge funds, appear to be moving into risky assets which can influence the stock's performance.
However, T2 had filed a Form S-3, documenting the resale of up to 141.64 million shares, which could have negative implications for existing shareholders. It could dilute shareholder value and exert downward pressure on the stock price.
Final Evaluation
In light of the current fundamental and technical analysis, as well as recent news, TTOO might be categorized as a Hold. Despite promising short-term positive signals of potential growth, the company's fundamental weaknesses, such as its negative EPS and PE ratio, combined with the planned share reselling, could lead to higher risk and limit upside potential in the long term. Therefore, holding the stock could be the safer option until further positive indicators or developments appear.
